Aspendos Tafla 100 mg Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

aspendos tafla 100 mg

medochemie limited - modafinilum inn - tafla - 100 mg

Conoxia Lyfjagas, fljótandi 100 % Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

conoxia lyfjagas, fljótandi 100 %

linde gas - oxygenium - lyfjagas, fljótandi - 100 %

Conoxia Lyfjagas undir þrýstingi 100 % Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

conoxia lyfjagas undir þrýstingi 100 %

linde gas - oxygenium - lyfjagas undir þrýstingi - 100 %

Cosopt sine Augndropar, lausn 20 mg/ml+5 mg/ml Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

cosopt sine augndropar, lausn 20 mg/ml+5 mg/ml

santen oy* - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20 mg/ml+5 mg/ml

Fixopost (Monoprostduo) Augndropar, lausn í stakskammtaíláti 50 míkróg/ml + 5 mg/ml Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

fixopost (monoprostduo) augndropar, lausn í stakskammtaíláti 50 míkróg/ml + 5 mg/ml

laboratoires thea* - latanoprostum inn; timololum maleat - augndropar, lausn í stakskammtaíláti - 50 míkróg/ml + 5 mg/ml

Modiodal Tafla 100 mg Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

modiodal tafla 100 mg

teva pharma b.v. - modafinilum inn - tafla - 100 mg

Xalcom Augndropar, lausn Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

xalcom augndropar, lausn

upjohn eesv - latanoprostum inn; timololum maleat - augndropar, lausn

Abasaglar (previously Abasria) Unió Europea - islandès - EMA (European Medicines Agency)

abasaglar (previously abasria)

eli lilly nederland b.v. - glargíninsúlín - sykursýki - lyf notuð við sykursýki - meðferð sykursýki hjá fullorðnum, unglingum og börnum 2 ára og eldri.

Adempas Unió Europea - islandès - EMA (European Medicines Agency)

adempas

bayer ag - riociguat - háþrýstingur, lungnabólga - blóðþrýstingslækkandi lyf fyrir lungnaháþrýsting - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. verkun hefur verið sýnt fram í pah íbúa þar á meðal orsökum sjálfvakin eða arfgengum pah eða pah tengslum við tengdum vef sjúkdómur. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.

Adrovance Unió Europea - islandès - EMA (European Medicines Agency)

adrovance

n.v. organon - colecalciferol, alendronic acid (as sodium trihydrate) - beinþynning, eftir tíðahvörf - lyf til að meðhöndla beinsjúkdóma - meðferð við beinþynningu eftir tíðahvörf hjá sjúklingum í hættu á d-vítamínskorti. hættan dregur úr hættu hryggjarliðum og mjöðm beinbrot.